UniProt ID | RN145_HUMAN | |
---|---|---|
UniProt AC | Q96MT1 | |
Protein Name | RING finger protein 145 {ECO:0000305} | |
Gene Name | RNF145 {ECO:0000312|PROSITE:PS50089} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 663 | |
Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein . |
|
Protein Description | E3 ubiquitin ligase that catalyzes the direct transfer of ubiquitin from E2 ubiquitin-conjugating enzyme to a specific substrate. In response to bacterial infection, negatively regulates the phagocyte oxidative burst by controlling the turnover of the NADPH oxidase complex subunits. Promotes monoubiquitination of CYBA and 'Lys-48'-linked polyubiquitination and degradation of CYBB NADPH oxidase catalytic subunits, both essential for the generation of antimicrobial reactive oxygen species. Involved in the maintenance of cholesterol homeostasis. In response to high sterol concentrations ubiquitinates HMGCR, a rate-limiting enzyme in cholesterol biosynthesis, and targets it for degradation. The interaction with INSIG1 is required for this function. In addition, triggers ubiquitination of SCAP, likely inhibiting its transport to the Golgi apparatus and the subsequent processing/maturation of SREBPF2, ultimately downregulating cholesterol biosynthesis.. | |
Protein Sequence | MAAKEKLEAVLNVALRVPSIMLLDVLYRWDVSSFFQQIQRSSLSNNPLFQYKYLALNMHYVGYILSVVLLTLPRQHLVQLYLYFLTALLLYAGHQISRDYVRSELEFAYEGPMYLEPLSMNRFTTALIGQLVVCTLCSCVMKTKQIWLFSAHMLPLLARLCLVPLETIVIINKFAMIFTGLEVLYFLGSNLLVPYNLAKSAYRELVQVVEVYGLLALGMSLWNQLVVPVLFMVFWLVLFALQIYSYFSTRDQPASRERLLFLFLTSIAECCSTPYSLLGLVFTVSFVALGVLTLCKFYLQGYRAFMNDPAMNRGMTEGVTLLILAVQTGLIELQVVHRAFLLSIILFIVVASILQSMLEIADPIVLALGASRDKSLWKHFRAVSLCLFLLVFPAYMAYMICQFFHMDFWLLIIISSSILTSLQVLGTLFIYVLFMVEEFRKEPVENMDDVIYYVNGTYRLLEFLVALCVVAYGVSETIFGEWTVMGSMIIFIHSYYNVWLRAQLGWKSFLLRRDAVNKIKSLPIATKEQLEKHNDICAICYQDMKSAVITPCSHFFHAGCLKKWLYVQETCPLCHCHLKNSSQLPGLGTEPVLQPHAGAEQNVMFQEGTEPPGQEHTPGTRIQEGSRDNNEYIARRPDNQEGAFDPKEYPHSAKDEAHPVESA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
9 (in isoform 2) | Phosphorylation | - | 22.87 | 22210691 | |
9 (in isoform 5) | Phosphorylation | - | 22.87 | 30631047 | |
11 (in isoform 5) | Phosphorylation | - | 5.71 | 30631047 | |
13 (in isoform 5) | Phosphorylation | - | 4.67 | 30631047 | |
15 (in isoform 5) | Phosphorylation | - | 5.03 | 30631047 | |
18 | Phosphorylation | LNVALRVPSIMLLDV HHHHHHCCHHHHHHH | 16.23 | - | |
18 (in isoform 2) | Phosphorylation | - | 16.23 | - | |
19 | Phosphorylation | NVALRVPSIMLLDVL HHHHHCCHHHHHHHH | 20.13 | 27732954 | |
20 (in isoform 5) | Phosphorylation | - | 1.52 | 30631047 | |
53 | Phosphorylation | NPLFQYKYLALNMHY CCCHHHHHHHHHHHH | 7.71 | 24043423 | |
60 | Phosphorylation | YLALNMHYVGYILSV HHHHHHHHHHHHHHH | 5.70 | 24043423 | |
63 | Phosphorylation | LNMHYVGYILSVVLL HHHHHHHHHHHHHHH | 6.66 | 24043423 | |
66 | Phosphorylation | HYVGYILSVVLLTLP HHHHHHHHHHHHHCC | 10.71 | 24043423 | |
71 | Phosphorylation | ILSVVLLTLPRQHLV HHHHHHHHCCHHHHH | 30.47 | 24719451 | |
298 | Phosphorylation | VLTLCKFYLQGYRAF HHHHHHHHHHHHHHH | 5.43 | - | |
352 | Phosphorylation | ILFIVVASILQSMLE HHHHHHHHHHHHHHH | 16.54 | - | |
507 (in isoform 1) | Ubiquitination | - | 29.54 | 21890473 | |
507 | Ubiquitination | LRAQLGWKSFLLRRD HHHHHCCCHHHHCHH | 29.54 | - | |
508 | Phosphorylation | RAQLGWKSFLLRRDA HHHHCCCHHHHCHHH | 18.02 | 24719451 | |
520 | Ubiquitination | RDAVNKIKSLPIATK HHHHHHHHCCCCCCH | 47.77 | - | |
520 (in isoform 1) | Ubiquitination | - | 47.77 | 21890473 | |
521 | Phosphorylation | DAVNKIKSLPIATKE HHHHHHHCCCCCCHH | 42.74 | - | |
527 (in isoform 1) | Ubiquitination | - | 34.15 | 21890473 | |
527 | Ubiquitination | KSLPIATKEQLEKHN HCCCCCCHHHHHHCC | 34.15 | - | |
532 | Ubiquitination | ATKEQLEKHNDICAI CCHHHHHHCCCEEEE | 57.19 | - | |
535 (in isoform 2) | Ubiquitination | - | 36.74 | 21890473 | |
535 | Ubiquitination | EQLEKHNDICAICYQ HHHHHCCCEEEEHHH | 36.74 | 21890473 | |
535 | Ubiquitination | EQLEKHNDICAICYQ HHHHHCCCEEEEHHH | 36.74 | 21890473 | |
535 | Ubiquitination | EQLEKHNDICAICYQ HHHHHCCCEEEEHHH | 36.74 | 21890473 | |
545 | Ubiquitination | AICYQDMKSAVITPC EEHHHCHHHCEEECC | 43.48 | - | |
548 (in isoform 2) | Ubiquitination | - | 6.90 | 21890473 | |
555 (in isoform 2) | Ubiquitination | - | 2.49 | 21890473 | |
562 | Ubiquitination | FFHAGCLKKWLYVQE HCCCCHHHHHHHHCC | 46.08 | - | |
563 | Ubiquitination | FHAGCLKKWLYVQET CCCCHHHHHHHHCCC | 29.50 | - | |
647 | Ubiquitination | QEGAFDPKEYPHSAK CCCCCCCCCCCCCCC | 72.26 | - | |
662 (in isoform 5) | Phosphorylation | - | 39.24 | 27642862 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RN145_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RN145_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RN145_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of RN145_HUMAN !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...